US · Healthcare · Medical Instruments & Supplies
EPS came in at 2.37 against a street estimate of 2.02 — a beat of 17.3%.
Analysts rate Intuitive Surgical Inc a buy (22 buy, 10 hold, 1 sell out of 33) with an average price target of $477.25.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.51% |
| Vanguard Capital Management, LLC | 6.53% |
| State Street Corp | 4.49% |
| T. Rowe Price Associates, Inc. | 3.54% |
| Amvescap Plc. | 3.17% |
| Geode Capital Management, LLC | 2.40% |
| Capital World Investors | 2.28% |
| Vanguard Portfolio Management, LLC | 2.05% |
| Document | Date |
|---|---|
| Charter / bylaws change · Q3 2026 | 2026-07-27 |
| Quarterly report · Q2 2026 | 2026-07-21 |
| Results announced · Q3 2026 | 2026-07-16 |
| Board / officer change · Q2 2026 | 2026-05-28 |
| Board / officer change · Q2 2026 | 2026-05-04 |
| Quarterly report · Q1 2026 | 2026-04-22 |
| Proxy statement · Q4 2025 | 2026-03-13 |
| Annual report FY2025 | 2026-02-03 |
Readable in the app.
| Announcement | Date |
|---|---|
| Completed acquisition of da Vinci and Ion distribution business Intuitive Surgical, Inc. announced on March 2, 2026, the completion of its acquisition of the da Vinci and Ion distribution business from ab medica, Abex, Excelencia Robótica, and their affi | 2026-03-02 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Intuitive Surgical Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.